NCT01510535 - Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis | Biotech Hunter

Enrollment

287

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

October 31, 2012

Conditions

Osteoarthritis of the Knee

Interventions

DRUG

Placebo

First 2 weeks Placebo(2ml) once weekly in experimental group

DRUG

Hyruan Plus

Hyruan Plus Inj. (2ml)once weekly for 3 weeks in control group

DRUG

LBSA0103

at third week LBSA0103(60mg) once in experimental group

Trial Locations (1)

Seoul National University Hospital, Jongno-gu